Episode

De-Extinction as a Platform Business with Colossal Biosciences

Podcast
Inevitable
Published
Sep 23, 2025
Duration seconds
2765
Processing state
not_requested
Canonical source
https://www.mcj.vc/media/podcast
Audio
https://cdn.simplecast.com/audio/a40ab607-6c05-44d6-b237-5cd4abd47ac6/episodes/31d8a636-333e-44f3-a3c4-1d690383ef6b/audio/d3284de1-9f40-4b7b-b7b4-2368fc5af57f/default_tc.mp3?aid=rss_feed&feed=XFfCG1w8
JSON
/v1/public/podcasts/inevitable-16764/episodes/de-extinction-as-a-platform-business-with-colossal-biosciences
Markdown
/podcast/inevitable-16764/de-extinction-as-a-platform-business-with-colossal-biosciences.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/inevitable-16764/episodes/de-extinction-as-a-platform-business-with-colossal-biosciences/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/inevitable-16764/de-extinction-as-a-platform-business-with-colossal-biosciences.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Ben Lamm is CEO and Co-founder of Colossal Biosciences, the world’s first de-extinction company. Colossal has raised more than $400 million at a valuation north of $10 billion to bring back extinct species using synthetic biology and genetic engineering. Just this year, the company unveiled the first dire wolves born in 12,000 years, created woolly mice with mammoth-like fur, and remains on track to see woolly mammoth calves by 2028. This conversation explores Colossal’s end-to-end platform approach, from ancient DNA recovery to multiplex genome editing, and why Ben sees de-extinction not just as science fiction come true but as a venture-scale business that spins out companies, partners with governments, and raises profound ethical questions. We cover polarizing public reactions, the conservation potential of rewilding keystone species, and how synthetic biology and AI are accelerating breakthroughs once thought impossible.